|
GB2377218A
(en)
*
|
2001-05-04 |
2003-01-08 |
Gw Pharmaceuticals Ltd |
Process and apparatus for extraction of active substances and enriched extracts from natural products
|
|
KR20070089151A
(ko)
|
2004-11-16 |
2007-08-30 |
지더블유 파마 리미티드 |
카나비노이드의 새로운 용도
|
|
GB0425248D0
(en)
|
2004-11-16 |
2004-12-15 |
Gw Pharma Ltd |
New use for cannabinoid
|
|
GB2460672B
(en)
*
|
2008-06-04 |
2012-01-04 |
Gw Pharma Ltd |
Cannabinoids in combination with non-cannabinoid chemotherapeutic agents that are alkylating agents
|
|
GB2471523A
(en)
|
2009-07-03 |
2011-01-05 |
Gw Pharma Ltd |
Use of tetrahydrocannibivarin (THCV) and optionally cannabidiol (CBD) in the treatment of epilepsy
|
|
GB2478595B
(en)
|
2010-03-12 |
2018-04-04 |
Gw Pharma Ltd |
Phytocannabinoids in the treatment of glioma
|
|
TWI583374B
(zh)
|
2010-03-30 |
2017-05-21 |
Ｇｗ伐瑪有限公司 |
使用植物大麻素次大麻二酚（ｃｂｄｖ）來治療癲癇之用途
|
|
GB2487712B
(en)
|
2011-01-04 |
2015-10-28 |
Otsuka Pharma Co Ltd |
Use of the phytocannabinoid cannabidiol (CBD) in combination with a standard anti-epileptic drug (SAED) in the treatment of epilepsy
|
|
GB2494461A
(en)
*
|
2011-09-12 |
2013-03-13 |
Gw Pharma Ltd |
Phytocannabinoids for use in the treatment of invasive cancers or metastases
|
|
GB2514054A
(en)
*
|
2011-09-29 |
2014-11-12 |
Gw Pharma Ltd |
A pharmaceutical composition comprising the phytocannabinoids cannabidivarin (CBDV) and cannabidiol (CBD)
|
|
GB201117956D0
(en)
*
|
2011-10-18 |
2011-11-30 |
Otsuka Pharma Co Ltd |
Phytocannabinoids for use in the treatment of breast cancer
|
|
US9776014B2
(en)
|
2012-05-03 |
2017-10-03 |
Magdent Ltd. |
Bone enhancement device and method
|
|
CA2895805A1
(en)
*
|
2012-12-18 |
2014-06-26 |
Kotzker Consulting Llc |
Use of cannabinoids and terpenes for treatment of organophosphate and carbamate toxicity
|
|
CA3012383C
(en)
|
2013-02-28 |
2021-03-02 |
Teewinot Technologies Limited |
Biosynthesis of cannabinoids
|
|
EP2968259B1
(en)
|
2013-03-14 |
2022-09-14 |
SC Laboratories Inc. |
Bioactive concentrates and uses thereof
|
|
US9095554B2
(en)
|
2013-03-15 |
2015-08-04 |
Biotech Institute LLC |
Breeding, production, processing and use of specialty cannabis
|
|
US10441617B2
(en)
|
2013-03-15 |
2019-10-15 |
Biotech Institute, Llc |
Breeding, production, processing and use of medical cannabis
|
|
GB2513167B
(en)
*
|
2013-04-18 |
2016-03-02 |
Otsuka Pharma Co Ltd |
Tetrahydrocannabivarin for use in the treatment of nausea and vomiting
|
|
GB2515312A
(en)
*
|
2013-06-19 |
2014-12-24 |
Gw Pharma Ltd |
The use of phytocannabinoids in the treatment of ovarian carcinoma
|
|
GB2516814B
(en)
*
|
2013-06-19 |
2016-08-31 |
Otsuka Pharma Co Ltd |
Use of phytocannabinoids for increasing radiosensitivity in the treatment of cancer
|
|
US10774288B2
(en)
*
|
2013-09-18 |
2020-09-15 |
The Werc Shop, LLC |
Terpene-based compositions, processes, methodologies for creation and products thereby
|
|
AU2014347807A1
(en)
*
|
2013-10-31 |
2016-05-26 |
Full Spectrum Laboratories, Ltd. |
Terpene and cannabinoid formulations
|
|
GB2530001B
(en)
|
2014-06-17 |
2019-01-16 |
Gw Pharma Ltd |
Use of cannabidiol in the reduction of convulsive seizure frequency in treatment-resistant epilepsy
|
|
GB2527599A
(en)
|
2014-06-27 |
2015-12-30 |
Gw Pharma Ltd |
Use of 7-OH-Cannabidiol (7-OH-CBD) and/or 7-OH-Cannabidivarin (7-OH-CBDV) in the treatment of epilepsy
|
|
GB2527590A
(en)
*
|
2014-06-27 |
2015-12-30 |
Otsuka Pharma Co Ltd |
Active pharmaceutical ingredient (API) comprising cannabinoids for use in the treatment of cancer
|
|
AU2015292915B2
(en)
|
2014-07-21 |
2020-10-15 |
Pharmaceutical Productions, Inc. |
Solid dosage form composition for buccal or sublingual administration of cannabinoids
|
|
JP6622793B2
(ja)
|
2014-08-25 |
2019-12-18 |
ティーウィノット テクノロジーズ リミテッド |
カンナビノイド化合物を同時作製する装置及び方法
|
|
CA2961410C
(en)
|
2014-09-16 |
2023-07-11 |
India Globalization Capital, Inc. |
Cannabinoid composition and method for treating pain
|
|
WO2016054268A1
(en)
|
2014-09-30 |
2016-04-07 |
MJAR Holdings, LLC |
Methods of growing cannabaceae plants using artificial lighting
|
|
GB2531278A
(en)
|
2014-10-14 |
2016-04-20 |
Gw Pharma Ltd |
Use of cannabidiol in the treatment of intractable epilepsy
|
|
GB2531281A
(en)
|
2014-10-14 |
2016-04-20 |
Gw Pharma Ltd |
Use of cannabidiol in the treatment of intractable epilepsy
|
|
GB2531282A
(en)
|
2014-10-14 |
2016-04-20 |
Gw Pharma Ltd |
Use of cannabinoids in the treatment of epilepsy
|
|
CN107205960A
(zh)
*
|
2014-10-21 |
2017-09-26 |
联合大麻公司 |
大麻提取物及其制备和使用方法
|
|
CN104277917B
(zh)
*
|
2014-10-24 |
2018-02-09 |
汉康(云南)生物科技有限公司 |
一种富含大麻二酚的工业大麻精油提取方法及其提取设备
|
|
WO2016105514A1
(en)
|
2014-12-23 |
2016-06-30 |
Biotech Institute, Llc |
A reliable and robust method for the analysis of cannabinoids and terpenes in cannabis
|
|
CA2974895A1
(en)
|
2015-01-25 |
2016-07-28 |
India Globalization Capital, Inc. |
Composition and method for treating seizure disorders
|
|
CA3012599A1
(en)
|
2015-01-26 |
2016-08-04 |
Matthew W. Giese |
Systems, apparatuses, and methods for classification
|
|
CA2974292C
(en)
|
2015-01-31 |
2024-04-16 |
Constance Therapeutics, Inc. |
Methods for preparation of cannabis oil extracts and compositions
|
|
US10238745B2
(en)
|
2015-01-31 |
2019-03-26 |
Constance Therapeutics, Inc. |
Cannabinoid composition and products including α-tocopherol
|
|
AU2016225026A1
(en)
*
|
2015-02-27 |
2017-09-07 |
Canopy Growth Corporation |
Compositions comprising combinations of purified cannabinoids, with at least one flavonoid, terpene, or mineral
|
|
CN107405314A
(zh)
*
|
2015-02-27 |
2017-11-28 |
埃布公司 |
包含纯化的大麻素与至少一种类黄酮、萜或矿物质的组合的组合物
|
|
US12303541B2
(en)
|
2015-04-01 |
2025-05-20 |
The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Center) |
Erodium crassifolium L'Her plant extracts and uses thereof
|
|
EP3277260B1
(en)
|
2015-04-01 |
2021-05-12 |
The State of Israel, Ministry of Agriculture & Rural Development, Agricultural Research Organization (ARO) (Volcani Center) |
Erodium crassifolium l'her plant extracts and uses thereof
|
|
CA2985065A1
(en)
*
|
2015-05-07 |
2016-11-10 |
Mark Andrew Scialdone |
Hydrogenation of cannabis oil
|
|
GB2539472A
(en)
|
2015-06-17 |
2016-12-21 |
Gw Res Ltd |
Use of cannabinoids in the treatment of epilepsy
|
|
EP3319446A4
(en)
*
|
2015-07-06 |
2019-07-03 |
Cg- Bio Genomics, Inc. |
Healthful supplements
|
|
US9585867B2
(en)
|
2015-08-06 |
2017-03-07 |
Charles Everett Ankner |
Cannabinod formulation for the sedation of a human or animal
|
|
GB2541191A
(en)
|
2015-08-10 |
2017-02-15 |
Gw Pharma Ltd |
Use of cannabinoids in the treatment of epilepsy
|
|
US10596159B2
(en)
|
2015-08-12 |
2020-03-24 |
India Globalization Capital, Inc. |
Method and composition for treating cachexia and eating disorders
|
|
WO2017091764A1
(en)
*
|
2015-11-24 |
2017-06-01 |
Constance Therapeutics, Inc. |
Cannabis oil compositions and methods for preparation thereof
|
|
MX421795B
(es)
*
|
2016-03-18 |
2025-03-14 |
Christopher Brian Reid |
Composiciones de extractos naturales y uso de los mismos para prevenir o tratar enfermedades
|
|
GB2548873B
(en)
|
2016-03-31 |
2020-12-02 |
Gw Res Ltd |
Use of Cannabidiol in the Treatment of SturgeWeber Syndrome
|
|
US10499584B2
(en)
|
2016-05-27 |
2019-12-10 |
New West Genetics |
Industrial hemp Cannabis cultivars and seeds with stable cannabinoid profiles
|
|
CA3027862A1
(en)
|
2016-06-15 |
2017-12-21 |
India Globalization Capital, Inc. |
Method and composition for treating seizure disorders
|
|
GB2551986A
(en)
|
2016-07-01 |
2018-01-10 |
Gw Res Ltd |
Parenteral formulations
|
|
GB2551987A
(en)
|
2016-07-01 |
2018-01-10 |
Gw Res Ltd |
Oral cannabinoid formulations
|
|
KR20190034576A
(ko)
*
|
2016-08-03 |
2019-04-02 |
젤다 테라퓨틱스 오퍼레이션즈 피티와이 엘티디 |
카나비스 조성물
|
|
BR112019001852A2
(pt)
*
|
2016-08-03 |
2019-05-07 |
Zelda Therapeutics Operations Pty Ltd |
composição de cannabis
|
|
SG11201900596XA
(en)
*
|
2016-08-03 |
2019-02-27 |
Zelda Therapeutics Operations Pty Ltd |
Cannabis composition
|
|
GB2553139A
(en)
|
2016-08-25 |
2018-02-28 |
Gw Res Ltd |
Use of cannabinoids in the treatment of multiple myeloma
|
|
US10568865B2
(en)
|
2016-08-29 |
2020-02-25 |
Canopy Growth Corporation |
Water soluble compositions comprising purified cannabinoids
|
|
US12485129B2
(en)
|
2016-08-29 |
2025-12-02 |
Canopy Growth Corporation |
Water soluble compositions comprising purified cannabinoids
|
|
GB2557921A
(en)
|
2016-12-16 |
2018-07-04 |
Gw Res Ltd |
Use of cannabinoids in the treatment of angelman syndrome
|
|
GB2559774B
(en)
|
2017-02-17 |
2021-09-29 |
Gw Res Ltd |
Oral cannabinoid formulations
|
|
GB2560019A
(en)
|
2017-02-27 |
2018-08-29 |
Gw Res Ltd |
Use of cannabinoids in the treatment of leukaemia
|
|
WO2018160827A1
(en)
*
|
2017-03-01 |
2018-09-07 |
Ebbu, LLC |
Compositions purposefully selected comprising purified cannabinoids and/or purified terpenes
|
|
EP3592346A4
(en)
*
|
2017-03-05 |
2020-12-30 |
The State of Isreal, Ministry of Agriculture & Rural Development, Agricultural Research Organization (ARO) |
COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER
|
|
WO2018205038A1
(en)
*
|
2017-05-12 |
2018-11-15 |
Tetra Bio-Pharma Inc. |
Compositions comprising cannabinoids and terpenes useful in the treatment of cancer and vascular ocular disorders via inhibition of hedgehog signalling
|
|
WO2018217803A2
(en)
*
|
2017-05-22 |
2018-11-29 |
Growblox Life Sciences L.L.C. |
Myrcene-containing complex mixtures targeting trpv1
|
|
KR20200104278A
(ko)
|
2017-06-19 |
2020-09-03 |
젤다 테라퓨틱스 오퍼레이션즈 피티와이 엘티디 |
수면 장애 조성물 및 그의 치료
|
|
JP2020524679A
(ja)
|
2017-06-20 |
2020-08-20 |
イッサム リサーチ デベロップメント カンパニー オブ ザ ヘブリュー ユニバーシティー オブ エルサレム エルティーディー． |
カンナビジオール酸エステル組成物およびその使用
|
|
GB2564383B
(en)
|
2017-06-23 |
2021-04-21 |
Gw Res Ltd |
Use of cannabidiol in the treatment of tumours assoicated with Tuberous Sclerosis Complex
|
|
EP3644976A4
(en)
*
|
2017-06-28 |
2021-03-24 |
Buzzelet Development And Technologies Ltd |
TERPEN-ENRICHED CANNABINOID PRODUCT FOR WOMEN'S HEALTH
|
|
CA3079537A1
(en)
*
|
2017-09-02 |
2019-03-07 |
Scientific Holdings, Llc |
Tetrahydrocannabinol modulators
|
|
GB2568929A
(en)
|
2017-12-01 |
2019-06-05 |
Gw Res Ltd |
Use of cannabinoids in the treatment of epilepsy
|
|
GB2569961B
(en)
|
2018-01-03 |
2021-12-22 |
Gw Res Ltd |
Pharmaceutical
|
|
CN108204786A
(zh)
*
|
2018-01-15 |
2018-06-26 |
武汉盛硕电子有限公司 |
一种基于手机模块的北斗测量系统
|
|
US10688191B2
(en)
|
2018-01-19 |
2020-06-23 |
Hr Biomed, Llc |
Delivery of a chemotherapy agent across the blood-brain barrier
|
|
AU2019210332A1
(en)
*
|
2018-01-22 |
2020-09-10 |
Pascal Biosciences Inc. |
Cannabinoids and derivatives for promoting immunogenicity of tumor and infected cells
|
|
WO2019157195A1
(en)
|
2018-02-08 |
2019-08-15 |
Neonc Technologies, Inc |
Methods of permeabilizing the blood brain barrier
|
|
KR102041875B1
(ko)
|
2018-02-14 |
2019-11-08 |
(주)카이언바이오텍 |
대마로부터 추출된 칸나비디올 추출물 및 트레일을 함유하는 대장암 예방 또는 치료용 약학 조성물
|
|
KR20190098649A
(ko)
|
2018-02-14 |
2019-08-22 |
(주)카이언바이오텍 |
칸나비디올 추출물을 함유하는 대장암 예방 또는 치료용 약학 조성물
|
|
EP3755318B1
(en)
*
|
2018-02-20 |
2022-08-24 |
MyMD Pharmaceuticals, Inc. |
Genetically modified cannabis sativa plants and modified cannabinoid compounds for treatment of substance addiction and other disorders
|
|
CA3095729A1
(en)
|
2018-03-30 |
2019-10-03 |
India Globalization Capital, Inc. |
Method and composition for treating cns disorders
|
|
EP3773722A1
(en)
|
2018-04-04 |
2021-02-17 |
Jay Pharma Inc. |
Combination of a cannabinoid and a chemotheraopeutic agent for the treatment of breast cancer
|
|
MX2020010603A
(es)
|
2018-04-09 |
2021-02-02 |
Ellevet Sciences |
Extracto de cáñamo para tratamiento de dolor en animales.
|
|
WO2019227167A1
(en)
*
|
2018-06-01 |
2019-12-05 |
The University Of Sydney |
Compositions and treatments
|
|
WO2020012315A1
(en)
|
2018-07-08 |
2020-01-16 |
Buzzelet Development And Technologies Ltd. |
Terpene-enriched cannabinoid composition for treatment of male subjects
|
|
EP3666765A1
(en)
*
|
2018-12-11 |
2020-06-17 |
Emerald Health Biotechnology España,S.L.U. |
Chromenic phytocannabinoids, their synthesis and use in treatment or prevention of disease
|
|
CA3123773A1
(en)
*
|
2018-12-12 |
2020-06-18 |
The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Center) |
Compositions and methods for the treatment of cutaneous t cell lymphoma (ctcl)
|
|
CA3128054A1
(en)
*
|
2019-01-31 |
2020-08-06 |
Cava Healthcare Inc. |
Compounds for increasing mhc-i expression and modulating histone deacetylase activity
|
|
NL2022614B1
(en)
*
|
2019-02-21 |
2020-08-31 |
Patrick Alexander Unger |
Pharmaceutical, phyto-cannabinoid based compositions
|
|
MX2021010875A
(es)
|
2019-03-12 |
2021-12-10 |
Epm Ip Inc |
Composiciones de éster de ácido cannabinoide y sus usos.
|
|
EP3946307A4
(en)
*
|
2019-04-02 |
2022-12-14 |
Ulagaraj Selvaraj |
SOLID NANOPARTICLE FORMULATION OF WATER-INSOLUBLE PHARMACEUTICAL SUBSTANCES WITH REDUCED OSTWALD RIPENING AND IMMEDIATE DRUG RELEASE AFTER INTRAVENOUS ADMINISTRATION
|
|
ES2986503T3
(es)
|
2019-05-03 |
2024-11-11 |
Zyus Life Sciences Inc |
Formulación para el manejo del dolor que comprende tetrahidrocannabinol (THC), cannabicromeno (CBC) y cannabidiol (CBD) en una proporción determinada
|
|
US12178797B2
(en)
|
2019-05-03 |
2024-12-31 |
Zyus Life Sciences Inc. |
Formulation for pain management
|
|
US12220396B2
(en)
|
2019-05-03 |
2025-02-11 |
Zyus Life Sciences Inc. |
Formulation for pain management
|
|
CA3140290A1
(en)
*
|
2019-05-16 |
2020-11-19 |
Technion Research & Development Foundation Limited |
Cannabinoids and uses thereof
|
|
GB201910389D0
(en)
|
2019-07-19 |
2019-09-04 |
Gw Pharma Ltd |
Novel compounds, methods for their manufacture, and uses thereof
|
|
GB2588576A
(en)
|
2019-08-27 |
2021-05-05 |
Gw Res Ltd |
Use of cannabinoids in the treatment of dyskinesia associated with Parkinson's disease
|
|
GB201916849D0
(en)
|
2019-11-19 |
2020-01-01 |
Gw Res Ltd |
Cannabidiol-type cannabinoid compound
|
|
GB201916846D0
(en)
|
2019-11-19 |
2020-01-01 |
Gw Res Ltd |
Cannabidiol-type cannabinoid compound
|
|
GB201916974D0
(en)
|
2019-11-21 |
2020-01-08 |
Gw Res Ltd |
Cannabidol-type cannabinoid compound
|
|
GB202002754D0
(en)
|
2020-02-27 |
2020-04-15 |
Gw Res Ltd |
Methods of treating tuberous sclerosis complex with cannabidiol and everolimus
|
|
CN111184710A
(zh)
*
|
2020-03-02 |
2020-05-22 |
福建省中科生物股份有限公司 |
一种环酚的应用和制备方法
|
|
CA3175684A1
(en)
|
2020-04-29 |
2021-11-04 |
Jon Penarando Saez |
Cannabinoids for use in supressing cancer stem cells
|
|
EP3912485A1
(en)
|
2020-05-18 |
2021-11-24 |
Del-Vis Sp. z o.o. |
Cigarette product and a method for manufacturing the product
|
|
CN111773390B
(zh)
*
|
2020-07-01 |
2021-08-20 |
南京大学 |
一种药物在制备治疗脑转移瘤及其相关疾病的药品中的应用
|
|
JP2023534073A
(ja)
*
|
2020-07-22 |
2023-08-07 |
ザ・ユニバーシティ・オブ・ブリティッシュ・コロンビア |
銀強化カンナビノイド抗生物質
|
|
EP4203925A1
(en)
*
|
2020-08-31 |
2023-07-05 |
Nelson Mandela University |
Cannabinoid combinations and their use in the treatment of cancer
|
|
US11160757B1
(en)
|
2020-10-12 |
2021-11-02 |
GW Research Limited |
pH dependent release coated microparticle cannabinoid formulations
|
|
US20240041902A1
(en)
*
|
2020-12-08 |
2024-02-08 |
The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization |
Compositions and methods for the treatment of urothelial cancer
|
|
WO2022215071A1
(en)
*
|
2021-04-05 |
2022-10-13 |
The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Institute) |
Compositions and methods for the treatment of cancer
|
|
WO2022232574A1
(en)
|
2021-04-29 |
2022-11-03 |
Tilray, Inc. |
Cannabidiol-dominant formulations, methods of manufacturing, and uses thereof
|
|
EP4422769A2
(en)
|
2021-10-26 |
2024-09-04 |
Ecofibre USA Inc. |
Systems and methods for producing hemp extracts and compositions
|
|
WO2023076937A1
(en)
|
2021-10-26 |
2023-05-04 |
Ecofibre Limited |
Methods of treating endometriosis and other non-cancer gynecological disorders with hemp extract
|
|
JP2024540177A
(ja)
|
2021-10-26 |
2024-10-31 |
エコファイバー ユーエスエイ インコーポレイテッド |
ヘンプ抽出物を使用する子宮内膜がんを処置する方法
|
|
WO2023130161A1
(en)
*
|
2022-01-10 |
2023-07-13 |
Dolce Cann Global Pty Ltd |
Compositions and methods for treating non-neurological disorders with combination products comprising a cannabinoid mixture rich in cannabidiolic acid (cbda) along with an additional active agent
|
|
WO2023130160A1
(en)
*
|
2022-01-10 |
2023-07-13 |
Dolce Cann Global Pty Ltd |
Compositions and methods for treating non-neurological disorders with combination products comprising a cannabinoid mixture rich in cannabidiolic acid (cbda).
|
|
US12440454B2
(en)
|
2022-02-01 |
2025-10-14 |
Portland Technology Holdings Llc |
Pharmaceutical compositions containing hemp extract for administration to felines and related methods
|
|
WO2023161921A2
(en)
*
|
2022-02-23 |
2023-08-31 |
Cannabotech Ltd. |
Compositions for use as an adjunctive therapy in the treatment of breast cancer
|
|
WO2023239415A1
(en)
*
|
2022-06-08 |
2023-12-14 |
Angrow Company Limited |
Compositions including cannabinoid and use thereof in the manufacture of a medicament for the treatment of inflammation in a subject
|
|
WO2023238114A1
(en)
*
|
2022-06-08 |
2023-12-14 |
The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Institute) |
Combinations and methods for the treatment of cancer
|
|
WO2024082014A1
(en)
*
|
2022-10-21 |
2024-04-25 |
Dolce Cann Global Pty Ltd |
Compositions comprising cannabidiolic acid and fatty acids
|
|
EP4608426A1
(en)
|
2022-10-26 |
2025-09-03 |
Ecofibre USA Inc. |
Stabilized compositions comprising cannabidiol
|
|
US12097211B2
(en)
|
2022-10-26 |
2024-09-24 |
Ecofibre USA Inc. |
Methods of treating estrogen sensitive diseases with cannabis extract
|
|
CN115583933B
(zh)
*
|
2022-10-31 |
2024-02-06 |
暨明医药科技（苏州）有限公司 |
一种高纯度四氢大麻素同系物的制备方法
|